Saturday, December 12, 2020 10:24:43 AM
On the recent "Akers Biosciences Business Update, Joshua Silverman, Lead Independent Director @ AKERS, said "I could say we feel very good about our current cash position with over $36 million and over $2 a share in cash".
This means that even with the very significant dilution of AKERS shares resulting from the more than doubling of shares outstanding, support for AKERS share price still remains at $2.00 a share.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM